Cephalexin Dosing for Uncomplicated Skin and Skin Structure Infections
For uncomplicated skin and skin structure infections, cephalexin should be administered at 500 mg orally 3-4 times daily for 5-7 days. 1, 2
Adult Dosing
- Standard dose: 500 mg orally every 6-8 hours (3-4 times daily)
- Alternative dosing: 500 mg orally every 12 hours (twice daily) 2
- Duration: 5-7 days for uncomplicated infections 1
- Maximum daily dose: 4 grams per day 2
For streptococcal infections, treatment should be continued for a minimum of 10 days to prevent complications such as rheumatic fever 2.
Pediatric Dosing
- Standard dose: 25-50 mg/kg/day divided into 4 doses 2
- Alternative dosing: Total daily dose may be divided and administered every 12 hours 2
- Weight-based dosing guide:
- 10 kg (22 lb): 125-250 mg (½-1 tsp of 125 mg/5 mL) four times daily
- 20 kg (44 lb): 250-500 mg (1-2 tsp of 125 mg/5 mL) four times daily
- 40 kg (88 lb): 500-1000 mg (2-4 tsp of 125 mg/5 mL) four times daily 2
Special Considerations
Severe Infections
- For more severe infections, dosage may be doubled 2
- If daily doses greater than 4 g are required, consider parenteral cephalosporins 2
Renal Impairment
- Dose adjustment required based on creatinine clearance 1
- Monitor renal function during treatment, especially in patients with pre-existing renal conditions
Clinical Efficacy
Cephalexin has demonstrated excellent clinical efficacy for uncomplicated skin and skin structure infections:
- Clinical cure rates of approximately 85% for uncomplicated skin infections 3
- Particularly effective against the most common pathogens in skin infections: Staphylococcus aureus and Streptococcus pyogenes 4
Alternative Agents
If cephalexin cannot be used due to allergies or other contraindications, consider:
- Clindamycin: 300-450 mg orally three times daily for 5-6 days 1
- Amoxicillin-clavulanate: 875/125 mg twice daily orally for 5-6 days 1
- Doxycycline: 100 mg twice daily 5
Common Pitfalls to Avoid
- Inadequate duration: For streptococcal infections, treat for a full 10 days to prevent complications 2
- Unnecessary MRSA coverage: In areas with low MRSA prevalence, broad-spectrum coverage may not be needed 1
- Failure to address underlying factors: Identify and manage predisposing conditions like venous stasis or diabetes 1
- Not elevating affected limb: Elevation helps reduce edema and improve healing 1
Monitoring Response
- Assess for clinical improvement within 72 hours of starting treatment 1
- Signs of improvement include decreasing erythema, warmth, swelling, and resolution of systemic symptoms 1
- If no improvement after 72 hours, consider:
- Reevaluation of diagnosis
- Drainage procedure if abscess present
- Change in antibiotic therapy 1
Cephalexin remains a first-line agent for uncomplicated skin and skin structure infections due to its excellent safety profile, good tissue penetration, and efficacy against the most common causative pathogens.